To translate a Summary of Product Characteristics (SmPC) and patient information leaflet (PIL) for the EU, render the approved English text into every required official language while keeping the QRD template structure, section numbering, and tables exactly intact, because EU regulators approve the product information by its structure as much as its wording. A centrally authorized medicine needs its product information in all 24 official EU languages plus Icelandic and Norwegian, which is 26 language versions of the same regulated document. Bluente, a format-preserving translation platform, keeps the QRD layout consistent across all of them.
Bluente is an AI-powered document translation platform used by 30,000+ professionals to translate files in 120+ languages while preserving original formatting. For regulatory affairs teams, the SmPC and PIL are among the highest-stakes translations in the business, because the language the regulator approves in English has to mean exactly the same thing in every translated version.
What Are the SmPC and PIL, and Why Are Their Translations Regulated?
The SmPC is the regulator-approved document that tells healthcare professionals how to use a medicine, and the PIL is the patient-facing leaflet that goes in the box. Both are part of the product information governed by EU pharmaceutical law, and their content and layout follow the Quality Review of Documents (QRD) template maintained by the European Medicines Agency.
Their translations are regulated because the product information is legally part of the marketing authorization. When a centrally authorized product is approved, every language version is part of that approval, so a mistranslation is not just a quality issue, it is a deviation from the authorized text. As one regulatory leader put it, in a highly regulated industry, when a document is approved in English and then gets translated, it has to carry the same context. That standard is what makes pharmaceutical translation different from ordinary document translation.
How Many Languages Does an EU Marketing Authorization Require?
A centrally authorized medicine requires its product information in all 24 official EU languages, plus Icelandic and Norwegian for the EEA, which totals 26 language versions of the SmPC, labelling, and PIL. Nationally authorized products require the official language or languages of each member state where the product is marketed, which can still mean a dozen or more versions for a product sold across Europe.
This volume is the core operational challenge. A single label change or safety update has to propagate accurately across all 26 versions, on a regulatory clock, without any version drifting in meaning or breaking the QRD layout. Translating each version manually and reformatting it into the template is exactly the slow, error-prone process that creates compliance risk. Bluente supports 120+ languages, covering every EU and EEA requirement from one platform.
Why Does Formatting Matter So Much for QRD-Compliant Documents?
Formatting matters because the QRD template prescribes the exact section structure, numbering, and headings of the SmPC and PIL, and regulators expect every language version to match that structure precisely. A translation that reflows sections, renumbers, or breaks the dosing tables is not QRD-compliant, even if the words are correct, and it gets sent back in review.
This is where general translation tools fail regulatory teams. Text-first tools strip the structure, forcing someone to manually rebuild the QRD layout in each of 26 languages, and that manual reformatting is both slow and a fresh source of errors. Bluente's layout-aware engine keeps the section numbering, headings, tables, and bullet structure intact through translation, so the output is already in QRD shape rather than needing to be reassembled.
How Do You Keep Medical Terminology Consistent and Accurate?
You keep terminology consistent by locking approved medical terms, MedDRA-aligned adverse-event wording, and product-specific phrasing to a glossary before translation, so the same term is rendered identically across every section and every language version. Terminology drift, where the same English term gets translated two different ways in different places, is a recurring problem in multi-translator pharmaceutical projects and a frequent review finding.
For high-stakes regulatory text, the right approach pairs a glossary with an iterative training process. Bluente supports a custom glossary that holds approved terminology constant, and for regulatory deployments works through a 4 to 6 week training loop where your team corrects less and less over time until the output matches your approved phrasing. This is how you get the contextual accuracy regulators expect, where the chosen term is not just a valid translation but the specific word the authorities approved.
Can AI Translate Regulatory Documents Safely?
AI can translate regulatory documents safely when it is paired with a controlled glossary, human review, and a security model that never exposes the data, which is the standard for regulatory affairs work in 2026. AI handles the speed problem, propagating a label change across 26 language versions in minutes instead of weeks, while human review and the glossary handle the accuracy and context the SmPC and PIL demand.
Security is non-negotiable for pre-approval product information, which is confidential until authorization. Bluente provides zero data retention, automatic deletion within 24 hours, end-to-end encryption, and SOC 2, GDPR, and ISO 27001 compliance, and your documents are never used to train AI models. That combination lets regulatory teams use AI speed without putting unpublished product information at risk.
Frequently Asked Questions
Q: How many languages does a centrally authorized EU product need?
A centrally authorized medicine needs its product information in all 24 official EU languages plus Icelandic and Norwegian, totaling 26 language versions of the SmPC, labelling, and PIL. Nationally authorized products need the official languages of each member state where they are sold.
Q: Will the QRD template structure survive translation?
With a format-preserving engine, yes. Bluente keeps the QRD section numbering, headings, and dosing tables intact through translation, so the output stays QRD-compliant rather than needing manual reassembly in each language.
Q: Is AI translation accurate enough for an SmPC?
AI gives a fast, accurate first pass, but the regulatory standard pairs it with a custom glossary and human review for the approved version. Bluente reaches 95 percent accuracy on specialized terminology and supports an iterative training loop to lock in your approved phrasing.
Q: How do you handle confidential pre-approval product information?
Use a platform with zero data retention and automatic deletion. Bluente deletes documents within 24 hours, encrypts end to end, is SOC 2, GDPR, and ISO 27001 compliant, and never uses your documents to train AI models, so unpublished product information stays protected.
Q: Can Bluente keep medical terminology consistent across all versions?
Yes. A custom glossary holds approved medical terms, MedDRA-aligned wording, and product names constant across every section and every language version, which prevents the terminology drift that regulators flag in review.
Q: What is the QRD template?
The QRD (Quality Review of Documents) template is the EMA-maintained standard that prescribes the structure, section numbering, and headings of the SmPC, labelling, and PIL. Every language version of a product's information has to follow it precisely.
Start translating documents for free. Bluente preserves your formatting across 120+ languages in under 2 minutes. [Try BluTranslate free](https://translate.bluente.com) — no credit card required.